|
|
MODIFIED CORN STARCH Drug Excipient Business Development Opportunity Report, 2024 |
$399.00 |
|
$399.00 |
|
|
MONOETHANOLAMINE Drug Excipient Business Development Opportunity Report, 2024 |
$399.00 |
|
$399.00 |
|
|
MANNITOL Drug Excipient Business Development Opportunity Report, 2024 |
$399.00 |
|
$399.00 |
|
|
MICROCRYSTALLINE CELLULOSE 101 Drug Excipient Business Development Opportunity Report, 2024 |
$399.00 |
|
$399.00 |
|
|
MENTHOL Drug Excipient Business Development Opportunity Report, 2024 |
$399.00 |
|
$399.00 |
|
|
MALTODEXTRIN Drug Excipient Business Development Opportunity Report, 2024 |
$399.00 |
|
$399.00 |
|